GLPBio

Nuclear Receptors

Products Related to Nuclear Receptors(13)

  • GC10195 structure
    GC10195Z-Guggulsterone
    CAS: 39025-23-5
    Purity: >98.00%

    Z-Guggulsterone is a steroidal plant active ingredient derived from Commiphora mukul and can promote cancer cell apoptosis.

  • GC10715 structure
    GC10715GSK 4112
    CAS: 1216744-19-2
    Purity: >98.00%

    GSK 4112 is a selective REV-ERBα agonist, with an EC 50 value of 0.4μM.

  • GC10908 structure
    GC10908AC 45594
    CAS: 13037-86-0
    Purity: >98%

    inverse agonist of steroidogenic factor 1 (SF-1)

  • GC10987 structure
    GC10987SID 7969543
    CAS: 868224-64-0
    Purity: >98%

    Selective steroidogenic factor-1 (SF-1, NR5A1) inhibitor

  • GC12035 structure
    GC12035SR9009
    CAS: 1379686-30-2
    Purity: >98.00%

    SR9009 is a potent REV-ERBα/β agonist with EC 50 values of 0.67μM and 0.8μM for REV-ERBα and REV-ERBβ, respectively.

  • GC13937 structure
    GC13937BIM5078
    CAS: 337506-43-1
    Purity: >98%

    HNF4α antagonist

  • GC14047 structure
    GC14047DLPC
    CAS: 18194-25-7
    Purity: >98.00%

    DLPC (DLPC) is an LRH-1 agonist ligand.

  • GC14284 structure
    GC14284SR 2211
    CAS: 1359164-11-6
    Purity: >98.50%

    inverse agonist of RORγ, potent and selective

  • GC15009 structure
    GC15009SR 1001
    CAS: 1335106-03-0
    Purity: >99.50%

    RORα and γ inverse agonist

  • GC15275 structure
    GC15275SR 8278
    CAS: 1254944-66-5
    Purity: >99.50%

    SR 8278 is an antagonist of the nuclear receptor REV-ERBα that can inhibit the transcription of REV-ERBα with an EC 50 value of 0.47μM.

  • GC17310 structure
    GC17310SR9011
    CAS: 1379686-29-9
    Purity: >99.50%

    REV-ERB-α/β agonist

  • GC17515 structure
    GC17515Δ4-Dafachronic Acid
    CAS: 23017-97-2
    Purity: >95.00%

    DAF-12 activator

  • GC17658 structure
    GC17658Guggulsterone
    CAS: 95975-55-6
    Purity: >98.00%

    Guggulsterone is a plant sterol extracted from the resin of the plant Commiphora wightii. Guggulsterone can inhibit the growth of a wide variety of tumor cells and induce apoptosis through downregulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP, and survivin), modulation of cell cycle proteins (such as Cyclin D1 and c-Myc), activation of caspases, inhibition of Akt, and activation of JNK.